N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study
Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed. This study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting...
Saved in:
Published in | Journal of the American College of Cardiology Vol. 71; no. 11; p. 1191 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Limited
20.03.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0735-1097 1558-3597 1558-3597 |
DOI | 10.1016/j.jacc.2018.01.021 |
Cover
Loading…
Abstract | Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.
This study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting.
Dyspneic patients presenting to 19 EDs in North America were enrolled and had blood drawn for subsequent NT-proBNP measurement. Primary endpoints were positive predictive values of age-stratified cutoffs (450, 900, and 1,800 pg/ml) for diagnosis of acute HF and negative predictive value of the rule-out cutoff to exclude acute HF. Secondary endpoints included sensitivity, specificity, and positive (+) and negative (-) likelihood ratios (LRs) for acute HF.
Of 1,461 subjects, 277 (19%) were adjudicated as having acute HF. The area under the receiver-operating characteristic curve for diagnosis of acute HF was 0.91 (95% confidence interval [CI]: 0.90 to 0.93; p < 0.001). Sensitivity for age stratified cutoffs of 450, 900, and 1,800 pg/ml was 85.7%, 79.3%, and 75.9%, respectively; specificity was 93.9%, 84.0%, and 75.0%, respectively. Positive predictive values were 53.6%, 58.4%, and 62.0%, respectively. Overall LR+ across age-dependent cutoffs was 5.99 (95% CI: 5.05 to 6.93); individual LR+ for age-dependent cutoffs was 14.08, 4.95, and 3.03, respectively. The sensitivity and negative predictive value for the rule-out cutoff of 300 pg/ml were 93.9% and 98.0%, respectively; LR- was 0.09 (95% CI: 0.05 to 0.13).
In acutely dyspneic patients seen in the ED setting, age-stratified NT-proBNP cutpoints may aid in the diagnosis of acute HF. An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF. |
---|---|
AbstractList | Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.
This study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting.
Dyspneic patients presenting to 19 EDs in North America were enrolled and had blood drawn for subsequent NT-proBNP measurement. Primary endpoints were positive predictive values of age-stratified cutoffs (450, 900, and 1,800 pg/ml) for diagnosis of acute HF and negative predictive value of the rule-out cutoff to exclude acute HF. Secondary endpoints included sensitivity, specificity, and positive (+) and negative (-) likelihood ratios (LRs) for acute HF.
Of 1,461 subjects, 277 (19%) were adjudicated as having acute HF. The area under the receiver-operating characteristic curve for diagnosis of acute HF was 0.91 (95% confidence interval [CI]: 0.90 to 0.93; p < 0.001). Sensitivity for age stratified cutoffs of 450, 900, and 1,800 pg/ml was 85.7%, 79.3%, and 75.9%, respectively; specificity was 93.9%, 84.0%, and 75.0%, respectively. Positive predictive values were 53.6%, 58.4%, and 62.0%, respectively. Overall LR+ across age-dependent cutoffs was 5.99 (95% CI: 5.05 to 6.93); individual LR+ for age-dependent cutoffs was 14.08, 4.95, and 3.03, respectively. The sensitivity and negative predictive value for the rule-out cutoff of 300 pg/ml were 93.9% and 98.0%, respectively; LR- was 0.09 (95% CI: 0.05 to 0.13).
In acutely dyspneic patients seen in the ED setting, age-stratified NT-proBNP cutpoints may aid in the diagnosis of acute HF. An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF. Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.BACKGROUNDContemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.This study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting.OBJECTIVESThis study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting.Dyspneic patients presenting to 19 EDs in North America were enrolled and had blood drawn for subsequent NT-proBNP measurement. Primary endpoints were positive predictive values of age-stratified cutoffs (450, 900, and 1,800 pg/ml) for diagnosis of acute HF and negative predictive value of the rule-out cutoff to exclude acute HF. Secondary endpoints included sensitivity, specificity, and positive (+) and negative (-) likelihood ratios (LRs) for acute HF.METHODSDyspneic patients presenting to 19 EDs in North America were enrolled and had blood drawn for subsequent NT-proBNP measurement. Primary endpoints were positive predictive values of age-stratified cutoffs (450, 900, and 1,800 pg/ml) for diagnosis of acute HF and negative predictive value of the rule-out cutoff to exclude acute HF. Secondary endpoints included sensitivity, specificity, and positive (+) and negative (-) likelihood ratios (LRs) for acute HF.Of 1,461 subjects, 277 (19%) were adjudicated as having acute HF. The area under the receiver-operating characteristic curve for diagnosis of acute HF was 0.91 (95% confidence interval [CI]: 0.90 to 0.93; p < 0.001). Sensitivity for age stratified cutoffs of 450, 900, and 1,800 pg/ml was 85.7%, 79.3%, and 75.9%, respectively; specificity was 93.9%, 84.0%, and 75.0%, respectively. Positive predictive values were 53.6%, 58.4%, and 62.0%, respectively. Overall LR+ across age-dependent cutoffs was 5.99 (95% CI: 5.05 to 6.93); individual LR+ for age-dependent cutoffs was 14.08, 4.95, and 3.03, respectively. The sensitivity and negative predictive value for the rule-out cutoff of 300 pg/ml were 93.9% and 98.0%, respectively; LR- was 0.09 (95% CI: 0.05 to 0.13).RESULTSOf 1,461 subjects, 277 (19%) were adjudicated as having acute HF. The area under the receiver-operating characteristic curve for diagnosis of acute HF was 0.91 (95% confidence interval [CI]: 0.90 to 0.93; p < 0.001). Sensitivity for age stratified cutoffs of 450, 900, and 1,800 pg/ml was 85.7%, 79.3%, and 75.9%, respectively; specificity was 93.9%, 84.0%, and 75.0%, respectively. Positive predictive values were 53.6%, 58.4%, and 62.0%, respectively. Overall LR+ across age-dependent cutoffs was 5.99 (95% CI: 5.05 to 6.93); individual LR+ for age-dependent cutoffs was 14.08, 4.95, and 3.03, respectively. The sensitivity and negative predictive value for the rule-out cutoff of 300 pg/ml were 93.9% and 98.0%, respectively; LR- was 0.09 (95% CI: 0.05 to 0.13).In acutely dyspneic patients seen in the ED setting, age-stratified NT-proBNP cutpoints may aid in the diagnosis of acute HF. An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF.CONCLUSIONSIn acutely dyspneic patients seen in the ED setting, age-stratified NT-proBNP cutpoints may aid in the diagnosis of acute HF. An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF. BackgroundContemporary reconsideration of diagnostic N-terminal pro–B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.ObjectivesThis study sought to evaluate the diagnostic performance of NT-proBNP for acute HF in patients with dyspnea in the emergency department (ED) setting.MethodsDyspneic patients presenting to 19 EDs in North America were enrolled and had blood drawn for subsequent NT-proBNP measurement. Primary endpoints were positive predictive values of age-stratified cutoffs (450, 900, and 1,800 pg/ml) for diagnosis of acute HF and negative predictive value of the rule-out cutoff to exclude acute HF. Secondary endpoints included sensitivity, specificity, and positive (+) and negative (−) likelihood ratios (LRs) for acute HF.ResultsOf 1,461 subjects, 277 (19%) were adjudicated as having acute HF. The area under the receiver-operating characteristic curve for diagnosis of acute HF was 0.91 (95% confidence interval [CI]: 0.90 to 0.93; p < 0.001). Sensitivity for age stratified cutoffs of 450, 900, and 1,800 pg/ml was 85.7%, 79.3%, and 75.9%, respectively; specificity was 93.9%, 84.0%, and 75.0%, respectively. Positive predictive values were 53.6%, 58.4%, and 62.0%, respectively. Overall LR+ across age-dependent cutoffs was 5.99 (95% CI: 5.05 to 6.93); individual LR+ for age-dependent cutoffs was 14.08, 4.95, and 3.03, respectively. The sensitivity and negative predictive value for the rule-out cutoff of 300 pg/ml were 93.9% and 98.0%, respectively; LR− was 0.09 (95% CI: 0.05 to 0.13).ConclusionsIn acutely dyspneic patients seen in the ED setting, age-stratified NT-proBNP cutpoints may aid in the diagnosis of acute HF. An NT-proBNP <300 pg/ml strongly excludes the presence of acute HF. |
Author | Gaggin, Hanna K Christenson, Robert H Peacock, W Franklin Chen-Tournoux, Annabel A Walters, Elizabeth L Hollander, Judd E Nagurney, John T Nowak, Richard M Pang, Peter S Patel, Darshita Levy, Phillip D Rivers, E Joy Doros, Gheorghe Januzzi, Jr, James L |
Author_xml | – sequence: 1 givenname: James L surname: Januzzi, Jr fullname: Januzzi, Jr, James L email: JJanuzzi@mgh.harvard.edu organization: Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts. Electronic address: JJanuzzi@mgh.harvard.edu – sequence: 2 givenname: Annabel A surname: Chen-Tournoux fullname: Chen-Tournoux, Annabel A organization: Division of Cardiology, Department of Medicine, Jewish General Hospital, Montreal, Quebec, Canada – sequence: 3 givenname: Robert H surname: Christenson fullname: Christenson, Robert H organization: Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland – sequence: 4 givenname: Gheorghe surname: Doros fullname: Doros, Gheorghe organization: Baim Institute for Clinical Research, Boston, Massachusetts; Department of Biostatistics, Boston University, Boston, Massachusetts – sequence: 5 givenname: Judd E surname: Hollander fullname: Hollander, Judd E organization: Department of Emergency Medicine, Jefferson University, Philadelphia, Pennsylvania – sequence: 6 givenname: Phillip D surname: Levy fullname: Levy, Phillip D organization: Department of Emergency Medicine, Wayne State University, Detroit, Michigan – sequence: 7 givenname: John T surname: Nagurney fullname: Nagurney, John T organization: Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts – sequence: 8 givenname: Richard M surname: Nowak fullname: Nowak, Richard M organization: Department of Emergency Medicine, Henry Ford Health System, Detroit, Michigan – sequence: 9 givenname: Peter S surname: Pang fullname: Pang, Peter S organization: Department of Emergency Medicine, Indiana University School of Medicine & Indianapolis EMS, Indianapolis, Indiana – sequence: 10 givenname: Darshita surname: Patel fullname: Patel, Darshita organization: Roche Diagnostics, Indianapolis, Indiana – sequence: 11 givenname: W Franklin surname: Peacock fullname: Peacock, W Franklin organization: Department of Emergency Medicine, Baylor College of Medicine, Houston, Texas – sequence: 12 givenname: E Joy surname: Rivers fullname: Rivers, E Joy organization: Roche Diagnostics, Indianapolis, Indiana – sequence: 13 givenname: Elizabeth L surname: Walters fullname: Walters, Elizabeth L organization: Department of Emergency Medicine, Loma Linda University Medical Center, Loma Linda, California – sequence: 14 givenname: Hanna K surname: Gaggin fullname: Gaggin, Hanna K organization: Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29544601$$D View this record in MEDLINE/PubMed |
BookMark | eNpd0DtOAzEUhWELgSABNkCBLNHQePAdP8amgyQ8pCiJINQjx7mBiTIPPJ4iu2EtrAwioKE6zadT_H2yX9UVEnIGPAEO-mqdrJ33ScrBJBwSnsIe6YFShglls33S45lQDLjNjki_bdecc23AHpKj1CopNYceySdsjqEsKrehs1CzWzbfNkgnLoaiCxgLT2fYxGKJtKhofEM6KjG8YuW3dIiNC7HEKl7T-Rt-fjwOphP2NBpPb4ajIX2O3XJ7Qg5WbtPi6e8ek5e70XzwwMbT-8fBzZg1qbCRaaOtyEB5J4z20mUpLAxqKY3DLEUrQaUWdeaUB7nSSw7SGOH5Qlo0bgXimFz-_Dahfu-wjXlZtB43G1dh3bX5dyRpVcr5jl78o-u6C98BfpSUIMVOnf-qblHiMm9CUbqwzf_SiS-jk3A- |
ContentType | Journal Article |
Copyright | Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited Mar 20, 2018 |
Copyright_xml | – notice: Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Mar 20, 2018 |
CorporateAuthor | ICON-RELOADED Investigators |
CorporateAuthor_xml | – name: ICON-RELOADED Investigators |
DBID | NPM 7T5 7TK H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jacc.2018.01.021 |
DatabaseName | PubMed Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-3597 |
ExternalDocumentID | 29544601 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Canada United States--US |
GeographicLocations_xml | – name: Canada – name: United States--US |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 6PF 7-5 71M 8P~ AABNK AABVL AACTN AAEDT AAEDW AAFTH AAIKJ AAKUH AALRI AAOAW AAQFI AAQQT AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ABVKL ACGFO ACGFS ACIUM ACJTP ACPRK ADBBV ADEZE ADVLN AEFWE AEKER AENEX AEVXI AEXQZ AFCTW AFETI AFRAH AFRHN AFTJW AGYEJ AHMBA AITUG AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ BAWUL BLXMC CS3 DIK DU5 E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 H13 HVGLF IHE IXB J1W K-O KQ8 L7B MO0 N9A NCXOZ NPM O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ Q38 RIG ROL RPZ SCC SDF SDG SDP SES SSZ T5K TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R 7T5 7TK ACVFH ADCNI AEUPX AFPUW AGCQF AIGII AKBMS AKYEP EFKBS H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-p239t-68693715ca386c4a721b8e6448ae72e941529e67a5c14f6d014883c0b49e8af13 |
ISSN | 0735-1097 1558-3597 |
IngestDate | Thu Jul 10 20:01:22 EDT 2025 Fri Jul 25 09:24:16 EDT 2025 Wed Feb 19 02:33:27 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | diagnosis NT-proBNP acute heart failure biomarker prognosis |
Language | English |
License | Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p239t-68693715ca386c4a721b8e6448ae72e941529e67a5c14f6d014883c0b49e8af13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 29544601 |
PQID | 2014441431 |
PQPubID | 2031078 |
ParticipantIDs | proquest_miscellaneous_2014952001 proquest_journals_2014441431 pubmed_primary_29544601 |
PublicationCentury | 2000 |
PublicationDate | 2018-03-20 20180320 |
PublicationDateYYYYMMDD | 2018-03-20 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-20 day: 20 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Journal of the American College of Cardiology |
PublicationTitleAlternate | J Am Coll Cardiol |
PublicationYear | 2018 |
Publisher | Elsevier Limited |
Publisher_xml | – name: Elsevier Limited |
References | 29544602 - J Am Coll Cardiol. 2018 Mar 20;71(11):1201-1203 |
References_xml | – reference: 29544602 - J Am Coll Cardiol. 2018 Mar 20;71(11):1201-1203 |
SSID | ssj0006819 |
Score | 2.6016946 |
Snippet | Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.
This... BackgroundContemporary reconsideration of diagnostic N-terminal pro–B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is... Contemporary reconsideration of diagnostic N-terminal pro-B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1191 |
SubjectTerms | Age Biomarkers Brain natriuretic peptide Cardiology Diagnosis Dyspnea Edema FDA approval Heart diseases Heart failure Medical diagnosis Medical prognosis Peptides Respiration |
Title | N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29544601 https://www.proquest.com/docview/2014441431 https://www.proquest.com/docview/2014952001 |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbhMxELVCkRAviDuFgoxEnypH8V5t3somUCJaEEqlvkX2rtOLihMtuxLKA78C38KXMbPeW1ArAS-raG1tJM_Z8XjmzFlCXvEglkpyJIWNBAsCZZjiC2zjkjr2NBdGY0X38Cg6OA6mJ-HJYPCjx1oqCz1M11f2lfyPVeEe2BW7ZP_Bsu1D4Qb8BvvCFSwM17-y8RGbOS7LJRL-2RuGp0rkH-fnZdWduPcJSSuZadiMk7bZcgzbUF40qUEAy27i7e6P3ifgWj9PPnwEA40rkuFG2bcXvvZaUmw__ZBUBNd-rn6qbLleV6yBad4yc_farHNyZixDNUO7LL85kqVV2lx2aVangGCaPjXHBu_aKsbL3JEF32FX5umZ6acyeNXb57mqjKndbyiYHzrGbuOf3SdaGhzynrdFcbortwGXkbgYXqgUZSq5cNKsG5NhdVdfKmBgqTOI6pzKpvh2M3SD3PTgHIKef_i94xBFEE_VnViONPjnH6LWdP2I648wVSgzu0vu1Eak-w5Q98jA2Pvk1mHNsnhA5h2uaIcr2sMVrXFFzy0FINAWV7TD1WsKqPr1cwNRtELUQ3L8djJLDlj9IQ628nxZsEhEKJsYpsoXURooWAgtDJ7slYk9IzEIlCaKVZjyYBFlmKUWfjrSgTRCLbj_iGzZpTVPCBWx0FLr1PAYpf6N9mA3lkKnmedpk2XbZKdZpXn9pn2de3jsDyCy59vkZTsMfhCLW8qaZenmSNQQgzmP3erOV06wZd6Y4Om1I8_I7Q6QO2SryEvzHKLNQr-oLP4bFgt7Tg |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=N-Terminal+Pro-B-Type+Natriuretic+Peptide+in+the+Emergency+Department%3A+The%C2%A0ICON-RELOADED+Study&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Januzzi%2C+Jr%2C+James+L&rft.au=Chen-Tournoux%2C+Annabel+A&rft.au=Christenson%2C+Robert+H&rft.au=Doros%2C+Gheorghe&rft.date=2018-03-20&rft.eissn=1558-3597&rft.volume=71&rft.issue=11&rft.spage=1191&rft_id=info:doi/10.1016%2Fj.jacc.2018.01.021&rft_id=info%3Apmid%2F29544601&rft.externalDocID=29544601 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0735-1097&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0735-1097&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0735-1097&client=summon |